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Abstract
Here, we present evidence that the tumor-like growth of mouse embryonic stem cells (mESCs) is suppressed by short-term
serum-free culture, which is reversed by pharmacological inhibition of Gsk3b. Mouse ESCs maintained under standard
conditions using fetal bovine serum (FBS) were cultured in a uniquely formulated chemically-defined serum-free (CDSF)
medium, namely ESF7, for three passages before being subcutaneously transplanted into immunocompromised mice.
Surprisingly, the mESCs failed to produce teratomas for up to six months, whereas mESCs maintained under standard
conditions generated well-developed teratomas in five weeks. Mouse ESCs cultured under CDSF conditions maintained the
expression of Oct3/4, Nanog, Sox2 and SSEA1, and differentiated into germ cells in vivo. In addition, when mESCs were
cultured under CDSF conditions supplemented with FBS, or when the cells were cultured under CDSF conditions followed
by standard culture conditions, they consistently developed into teratomas. Thus, these results validate that the
pluripotency of mESCs was not compromised by CDSF conditions. Mouse ESCs cultured under CDSF conditions proliferated
significantly more slowly than mESCs cultured under standard conditions, and were reminiscent of Eras-null mESCs. In fact,
their slower proliferation was accompanied by the downregulation of Eras and c-Myc, which regulate the tumor-like growth
of mESCs. Remarkably, when mESCs were cultured under CDSF conditions supplemented with a pharmacological inhibitor
of Gsk3b, they efficiently proliferated and developed into teratomas without upregulation of Eras and c-Myc, whereas
mESCs cultured under standard conditions expressed Eras and c-Myc. Although the role of Gsk3b in the self-renewal of ESCs
has been established, it is suggested with these data that Gsk3b governs the tumor-like growth of mESCs by means of a
mechanism different from the one to support the pluripotency of ESCs.
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Introduction
Embryonic stem cells (ESCs) [1,2,3] and induced pluripotent
stem cells (iPSCs) [4,5,6,7] are very promising tools for use in drug
screening and customized tissue replacement [8] because they are
capable of self-renewal that sustains pluripotency. The self-renewal
and pluripotency of mouse stem cells (ESCs and iPSCs) are
maintained by extrinsic factors, such as supplementing basal
culture medium with leukemia inhibitory factor (LIF)
[9,10,11,12,13] and fetal bovine serum (FBS). FBS further
facilitates their self-renewal by offering other factors, such as bone
morphogenetic protein 4 (Bmp4) [14], retinoids [15,16,17],
threonine [18] and glutathione [19]. However, FBS also provides
cultures with many other uncharacterized components that may
affect the capability of ESCs and iPSCs to self-renew and
differentiate. Undefined culture conditions using animal sera
may have contributed to results finding contradictory roles of the
Wnt signaling pathway in ESCs [20,21,22,23]. However, it is now
firmly established that pharmacological inhibition of glycogen
synthase kinase 3b (Gsk3b) promotes the self-renewal of both
mouse [22,24] and human ESCs [23], and derivation of mouse
ESCs [25].
To eliminate the effects of unknown components in animal sera
as well as the contamination of animal products, chemically-
defined serum-free culture methods have been established
[14,26,27,28]. Typically, defined culture media are composed of
critical growth factors (e.g., LIF and/or Bmp4) and other factors
present in animal sera, such as hormones (e.g., insulin and
transferrin), vitamins, fatty acids and minerals. Commercially-
made serum replacements that may contain these components in
animal sera [29] are often used to maintain ESC culture (e.g.,
[30]), although the exact components cannot be disclosed by their
patents [28]. The maintenance of the undifferentiated state of
mouse ESCs (mESCs) using defined culture media has been well
documented [31,32]. Furthermore, the pluripotency of these
mESCs has been validated by their differentiation in vitro [26,32]
or by the development of chimeric mice [14].
Another way to validate the pluripotency of ESCs and iPSCs is
to examine the ability of these cells to develop into tumors called
teratomas after their transplantation into immunocompromised
mice [33,34,35]. Such teratoma formation assays have validated
the pluripotency of mESCs maintained in the presence of a Gsk3b
inhibitor [23,25]. This method, which requires no special
technique or equipment and reduces the use of experimental
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validation of pluripotency in human ESCs and iPSCs [13,36].
However, their tumor-like growth hampers the therapeutic
application of human iPSCs [37]. Little is known about the
inherent tumorigenic property of ESCs, except that the oncogene
Eras regulates the tumor-like growth of mESCs via activation of
Akt1 [38], which may result in inactivation of Gsk3b [24,39,40].
However, human ESCs do not express human ERAS [41,42], but
grow into teratomas [3]. Therefore, the underlying mechanism
involved in the tumor-like growth of ESCs remains unknown.
On the other hand, mESCs contribute to the development of
normal chimeras, instead of forming teratomas, when mixed with
mouse preimplantation embryos. This finding indicates that
mESCs require proper extrinsic signals or niches [43] to
differentiate normally and to contribute to the development of
chimeras. In contrast, mESCs exhibit cell death when they are
cultured without LIF [26,44]. This result raises the question of
whether mESCs inherently possess the tumor-like property or are
provided with extrinsic signals that promote their tumorigenesis.
In this report, we present experimental evidence that short-term
serum-free culture reduces the tumorigenicity of mESCs, which is
reversed by pharmacological inhibition of Gsk3b. It is suggested
with these data that the activity of Gsk3b orchestrates the tumor-
like growth of ESCs, which may support a novel mechanism
independent from the one regulating the pluripotency of ESCs.
Results
Mouse embryonic stem cells reduced their
tumorigenicity but maintained their pluripotency under
chemically-defined serum-free culture
To examine whether mESCs are determined to grow as
teratomas, we cultured mESCs in chemically-defined serum-free
medium with LIF (referred to as ‘‘CDSF’’) [26] for three passages
(Fig. 1A, 1C) and subcutaneously transplanted them into non-
obese diabetic mice with severe combined immunodeficiency
disease (NOD-SCID mice) [45]. We used a uniquely formulated
serum-free medium, ESF7 (see Materials and Methods), because
components in this medium is fully disclosed [26]. This medium
has been used to maintain mESCs by other studies (e.g., [46,47]).
However, the pluripotency of mESCs cultured under this medium
has not been tested by teratoma formation assays. Surprisingly,
these mESCs failed to grow as teratomas (Fig. 1F-1H), whereas
mESCs maintained under standard conditions (Fig. 1A, 1B) grew
into a well-developed teratoma in 5 weeks (Fig. 1F, 2A–2E, and
supporting information Fig. S1A). When mESCs were cultured in
CDSF supplemented with 15% FBS (referred to as ‘‘CDSF+FBS’’;
Fig. 1A, 1D), they formed a well-developed teratoma in 5 weeks
(Fig. 1G, 2F–2J, and supporting information Fig. S1B). Thus,
tumorigenesis in mESCs is not simply inhibited by CDSF
conditions. When the injections were properly performed, we
did not observe blood coming out of the injection sites. Only
properly performed injections were counted in the present study.
We conclude that CDSF did not compromise the pluripotency
of mESCs per se for the following reasons. First, throughout the
culture period (three passages, 9–12 days), the transcriptional
activity of the master regulator of pluripotency, Oct3/4 (Pou5f1)
[48,49,50], was validated using a mESC line that expresses the
enhanced green fluorescent protein (EGFP) under the Oct3/4
promoter [51] (Fig. 1B, 1C). Unless otherwise noted, this mESC
line was used throughout the present study. Next, immunofluo-
rescence microscopy confirmed that the mESC line cultured under
CDSF conditions maintained the expression of Nanog, Sox2, and
SSEA1 (Fig. 3A–3C). In addition, when the mESC line cultured
under CDSF conditions was aggregated with wild-type morulae,
resulting chimeric blastocysts exhibited green fluorescence in the
inner cell mass (Fig. 3E). Eleven days after these blastocysts were
transferred to pseudopregnant females, fluorescent cells were
detected in a nascent male gonad of an embryo at embryonic day
13.5 (Fig. 3F, 3G).
Furthermore, when the mESC line was maintained in either
CDSF+FBS (n=4) or CDSF for three passages and brought back
to the standard medium for one or two passages (referred to as
‘‘CDSF-Standard’’, n=4; Fig. 1A), EGFP expression was
maintained (Fig. 1D, 1E) and the cells became teratomas
(Fig. 1G, 1H, and 2F–2O; p,0.00016, see supporting information
Table S1 and Fig. S1B, S1C). Similar results were obtained using
four different lots of FBS. These data demonstrate that
tumorigenesis in mESCs can be suppressed by short-term culture
in the serum-free medium. The plasticity of tumorigenicity in
mESCs appears to be unique; embryonic carcinomas (F9) [52],
which are also pluripotent stem cells, formed teratomas when
cultured in CDSF and transplanted (supporting information Fig.
S1D). Likewise, germline-incompetent mESCs, D3, grew into
teratomas (data not shown).
Mouse embryonic stem cells cultured under serum-free
conditions exhibited longer doubling time while
maintained expression of genes associated with cellular
pluripotency
When NOD-SCID mice transplanted with mESCs reached their
end points, they were sacrificed and examined for teratomas. This
procedure usually yielded teratomas of about 30 mm in diameter
(bars in Fig. 4A). However, the number of days needed for the
experimental animals to reach their end points varied (stars in
Fig. 4A). Interestingly, it took 4763.1 days for mESCs cultured in
CDSF+FBS to grow into 30 mm teratomas, whereas it took 3761.8
days for mESCs cultured in CDSF followed by standard conditions
for two passages to reach 30 mm in diameter. However, when
mESCs cultured in CDSF were passaged only once into standard
conditions, it took 76 days for these mESCs to grow into a 30 mm
teratoma. Although this sample size is too small to be statistically
significant, it is suggested with these data that CDSF may even
suppress the growth of teratomas.
Among the experimental NOD-SCID mice examined in this
study, two out of the seven mice had mESCs cultured in CDSF
injected into one side of the animal and mESCs cultured in media
containing FBS injected into the other side. Therefore, the formation
of teratomas from mESCs cultured in CDSF could not be examined
beyond the end point of the animals (Fig. 4A). However, in the other
five animals, we were able to determine that transplanted mESCs
under CDSF did not generate teratomas for up to 6 months.
At one injection site, we were able to identify a tiny mass of
mESCs that had been cultured under CDSF-Standard conditions
one week after transplantation (supporting information Fig. S1E).
The mESCs in this mass had the appearance of cells undergoing
initial differentiation (supporting information Fig. S2). However,
we did not observe any cellular mass at the injection sites that were
derived from mESCs cultured in CDSF at either one week or six
months after transplantation.
Mouse ESCs cultured in CDSF exhibited a significantly longer
doubling time (,28 hrs) than ones cultured under standard
conditions (,17 hrs, p,0.005) during the first two passages, whereas
ones cultured in CDSF+F B So ru n d e rC D S F - S t a n d a r dc o n d i t i o n s
took ,19 and ,20 hrs to divide, respectively (Fig. 4B, top). Similar
results were obtained with another mESC line, W4 [53,54] (data not
shown). The differences in doubling times of mESCs were evident as
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S.E.M. of 0.0967 vs. 2.72 doublings 6 S.E.M. of 0.0923 for the
standard condition in 48 hrs, p,0.005). Despite the longer doubling
time, mESCs cultured in CDSF did proliferate steadily (Fig. 4B,
bottom). Additionally, transcripts associated with cellular pluripoten-
cy, Sox2, Esg1/Dppa5 and Oct3/4, were expressed in mESCs cultured
in CDSF (Fig. 4C). Interestingly, Eras, which regulates the
tumorigenic growth of mESCs [38], was downregulated in these
mESCs (Fig. 4C), whereas it became upregulated when mESCs were
maintained in CDSF+FBS or under CDSF-Standard conditions
(Fig. 4C, see also supporting information Fig. S5). Collectively, the
loss of tumor-like potential in mESCs cultured under CDSF is
associated with a slower growth rate and the reduced expression of
Eras. It is interesting to note that Eras-null mESCs can contribute to
the germline in chimeric animals but show significantly reduced
growth rate [38].
Pharmacological inhibition of Gsk3b reversed the effect
of serum-free culture on the tumor-like growth of mouse
embryonic stem cells
To identify a potential serum factor responsible for inducing the
tumor-like growth in mESCs, initially we focused on molecules
known to sustain the self-renewing growth of mESCs, such as LIF
[9,10], Bmp4 [14], vitamin A derivatives (all-trans retinoic acid,
RA [15], and retinol [16,17]), and simultaneous inhibition of Erk
and Gsk3b [31]. Pharmacological inhibition of Gsk3b alone
promotes self-renewal of both mouse and human ESCs [23]. We
excluded LIF from screening because CDSF contains LIF [26]. In
the absence of LIF, mESCs undergo differentiation or cell death
[26,44]. We also ruled out an inhibitor of Erk [31], which acts
downstream of FGF receptors, because inhibition of Erk cannot
promote the growth of mESCs [31]. Therefore, we focused on
testing other molecules such as Bmp4, RA, retinol with or without
retinol binding protein (RBP) [55], and an inhibitor of Gsk3b
(CIHR99021) [31].
Addition of RA in CDSF induced differentiation of mESCs as
evidenced by the reduced expression level of EGFP (supporting
information Fig. S3A). Addition of retinol with or without RBP in
CDSF did not induce differentiation of mESCs (supporting
information Fig. S3B, S3C), but failed to accelerate their growth
and to induce teratoma formation (Fig. 5A, 5B). In contrast,
mESCs cultured in CDSF with Bmp4 or the Gsk3b inhibitor
maintained Oct3/4 expression (supporting information Fig. S3D,
S3E), increased the number of cell doublings (Fig. 5A) and formed
teratomas in 17% or 67% of transplantations by 7 months,
respectively (Fig. 5B, 5C and supporting information Fig. S1F,
Figure 1. The tumorigenicity of mouse embryonic stem cells can be reduced by short-term serum-free culture. (A): A mouse embryonic
stem cell (mESC) line harboring an EGFP reporter driven by the Oct3/4 promoter (Oct3/4::EGFP) was maintained in either standard or chemically-
defined serum-free (CDSF) medium as indicated. (B–E): Phase contrast (left) and fluorescence (right) images of the ESC line under the conditions
indicated above are shown. Bars, 20 mm. (F–H): After the mESCs were cultured as indicated, they were transplanted into NOD-SCID mice
subcutaneously. Teratoma formation was observed by week 11. Bars, 1 cm.
doi:10.1371/journal.pone.0021355.g001
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mented with N2 [56], B27 [57], and either Bmp4 and LIF [14], or
pharmacological inhibitors of Erk and Gsk3b [22], mESCs grew
into teratomas more efficiently (see ‘‘N2B27-BL’’ and ‘‘N2B27-2i’’
in supporting information Table S1 and Fig. S4). Also, W4 mESCs
exhibited similar phenotypic changes when maintained in CDSF
with the Gsk3b inhibitor (Fig. 5B). Gsk3b is known to regulate the
activity of the c-Myc protein in mESCs [24,58]. However, RT-
PCR analysis showed that inhibition of Gsk3b did not result in
upregulation of Eras and c-Myc in mESCs cultured in CDSF,
whereas Bmp4 induced upregulation of c-Myc (Fig. 5D and
supporting information Fig. S5).
Discussion
In this report, we present experimental evidence to suggest that
short-term CDSF culture reduces the tumor-like growth of
mESCs, which is reversed by pharmacological inhibition of
Figure 2. Identification of three germ layers in teratomas. (A–E): Teratomas developed from mESCs cultured under standard conditions. (F–J):
Teratomas developed from mESCs cultured in CDSF supplemented with 15% FBS (CDSF+FBS). (K–O): Teratomas developed from mESCs cultured in
CDSF followed by transfer to standard conditions (CDSF to Stand). Ectoderm is represented by neural tissue and keratin pearl, mesoderm is
represented by cartilage and striated muscle, and endoderm is represented by ciliated epithelium. Bars, 20 mm.
doi:10.1371/journal.pone.0021355.g002
Figure 3. Mouse embryonic stem cells cultured under CDSF conditions are pluripotent. (A–D): Mouse ESCs cultured under CDSF
conditions were immunostained (right) with either specific antibodies against Nanog (A), Sox2 (B) and SSEA1 (C), or normal mouse serum (D). Also,
phase contrast (left), and DAPI-stained (middle) images of these mESCs are shown. Bars, 20 mm. (E): Phase contrast (left) and fluorescence (right)
images of a chimeric blastocyst aggregated with the Oct3/4::EGFP mESC line. Bar, 20 mm. (F): A phase contrast image of a male gonad dissected from
a chimeric E13.5 embryo. The rectangle indicates the area shown in G. Bar, 100 mm. (G): Enlarged phase contrast (left) and fluorescence (right) images
of the male gonad shown in F. Bar, 50 mm.
doi:10.1371/journal.pone.0021355.g003
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primarily responsible for tumorigenesis in mESCs, which may
involve uncharacterized gene products. Although the exact
mechanism currently remains unknown, our present study
provides a basis for further study to establish the signaling
pathway responsible for the tumor-like property of ESCs.
In general, serum provides hormones, growth factors, and
steroids to cultured cells. It also contains remnants of plasma
components used for the activation and processing of blood clots
and substances that do not normally pass through the endothelial
barrier [59,60,61]. Therefore, serum is similar but not identical to
the interstitial fluid (i.e., lymph) that surrounds cells in vivo [62]. We
were unable to observe any cellular mass at the injection sites that
were derived from mESCs cultured in CDSF at either one week or
six months after transplantation. Therefore, it is suggested with
our data that interstitial fluid will not support the tumor-like
growth of mESCs.
Perhaps mESCs cultured under short-term CDSF conditions
became more susceptible to LIF and exhibited cell death after
transplantation due to the absence of a continuous supply of LIF
[26]. However, because each mESC line shows a different degree
of LIF dependency [54], other mouse pluripotent stem cells
cultured in the serum-free medium may exhibit a capability to
continuously grow after transplantation, as we have seen in
embryonic carcinomas (F9; supporting information Fig. S1D) and
germline-incompetent mESCs, D3 (data not shown). In addition,
we found that the formation of teratomas became sporadic when
we transplanted 0.5610
6 mESCs cultured under standard
conditions for a period of 6 months. Collectively, our study
demonstrated that one or more extrinsic factors or niche [43] plays
an important role in the formation of a teratoma. This idea is
further supported by the fact that two mESCs were sufficiently
able to grow into a teratoma only when mixed with 2610
6 non-
tumorigenic fibroblasts (MRC-5) prior to transplantation into
immunocompromised mice [63]. Interestingly, the slow growth
observed in Eras-null mESCs became more evident when they
were cultured without feeder cells [38].
Our present data indicate that animal sera contain one or more
factors that inhibit the activity of the Gsk3b protein (Fig. 1, 4 and
5). Gsk3b is involved in the canonical Wnt signaling pathway
[64,65,66] and interacts with other biologically important
signaling pathways such as phosphoinositide 3-kinase (PI3K)-
Akt1 [40,67,68], Bmp4 [69] and hedgehog [70,71,72] signaling
pathways. Although the secreted protein Wnt eventually inhibits
the activity of Gsk3b, the role of Wnt in the maintenance of self-
renewal and pluripotency of ESCs remains elusive [20,21,22,23].
Figure 4. Phenotypic changes observed in mouse embryonic stem cells cultured under CDSF conditions. (A): The sizes of the teratomas
formed (orange bar, left axis) and the number of days required for the experimental NOD-SCID mice to reach their end points (blue stars, right axis)
were compared among mESCs cultured under the conditions indicated (see Fig. 1A). Parentheses indicate the number of biological replicates (i.e.,
mESCs prepared at different passages) per culture condition. Standard errors of the means are indicated by bars.
a: Only one passage in standard
conditions followed CDSF culture.
b: Two out of seven transplantations showed no sign of teratoma formation when paired with the standard and
CDSF-Standard conditions, whereas five out of seven transplantations showed no sign of teratoma formation for 6 months. (B, top): Cell doublings
were measured every 48 hours after plating 1610
6 cells per well onto 6-well plates (see Materials and Methods for the formula). Only CDSF conditions
produced statistically-significant differences compared to standard conditions. Parentheses indicate the number of biological replicates per
condition. Standard errors of the means are indicated by bars. (B, bottom): Phase contrast (top) and fluorescence (bottom) images are shown for the
Oct3/4::EGFP mESC line (Fig. 1A) grown under the conditions indicated below 1 and 2 days after plating 0.1610
6 cells per well in 6-well plates. Bars,
50 mm. (C): Abundance of each transcript indicated above was examined in mESCs cultured under each condition on the right by 25 cycles of PCR.
Ef1a was used as a reference.
doi:10.1371/journal.pone.0021355.g004
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the self-renewal and pluripotency of ESCs [22,23,24,25]. Now, the
question is what Gsk3b upstream and downstream genes are in
self-renewing ESCs.
Both LIF-Stat3 [73,74] and insulin pathways activate the PI3K-
Akt1 signaling pathway [24,68], which mediates the inactivation of
Gsk3b [24,40,64]. However, CDSF includes LIF and insulin [26],
and failed to support the tumor-like growth of mESCs (Fig. 1 and
4). Thus, LIF and insulin are not the upstream of Gsk3b. Because
Eras activates Akt1 [38], the downregulation of Eras in mESCs
cultured in CDSF (Fig. 4C and 5D) may have resulted in the
activation of Gsk3b. However, human ESCs do not express
human ERAS but they do grow into teratomas [41,42]. Because
this signaling cascade is not evolutionarily conserved, Eras is not
the upstream of Gsk3b.
Based on our results, Bmp4 poorly promoted proliferation and
teratoma formation of mESCs cultured under CDSF conditions
(Fig. 5A, 5B). It is well known that the Bmp4 and Wnt signals
interact with each other in many morphogenetic events, which
could result in either synergistic or antagonistic effects depending
on cell types [69]. Because of the following two observations, we
consider the effect of Bmp4 on Gsk3b or the tumor-like growth of
mESCs antagonistic or indirect. First, our RT-PCR results
revealed that mESCs cultured in CDSF supplemented with
Bmp4 upregulated c-Myc, which was not the case in mESCs
treated with the Gsk3b inhibitor (Fig. 5D and supporting
information Fig. S5). Second, in one set of our experiments,
Bmp4 efficiently induced formation of teratomas when ESCs at
the earlier passage number (passage 7) were used for the culture
(see (ii) in Fig. 5B). In contrast, when mESCs at passage 9 or later
Figure 5. Screening of factors responsible for the tumor-like growth of mouse embryonic stem cells. (A): Cumulative numbers of mESCs
were compared among ESCs cultured under each condition indicated for 3 passages. Cell counts were normalized to CDSF conditions. A value for
CDSF conditions is normalized to 1. Parentheses indicate the number of biological replicates per condition. Standard errors of the means are
indicated by bars. +RA, CDSF with retinoic acid; +RL, CDSF with retinol; +RL+RBP, CDSF with retinol and retinol binding protein; +Bmp4, CDSF with
Bmp4; +iGsk3b, CDSF with the Gsk3b inhibitor. (B): Total numbers of biological replicates that resulted in formation of teratomas were compared
among mESCs cultured under each condition indicated. Orange and yellow boxes indicate the number of biological replicates that developed into
teratomas within 6 months and in more than 6 months, respectively. Blue bars indicate the number of biological replicates that failed to form
teratomas for more than 6 months. Data for the Gsk3b inhibitor include results obtained with R1 and W4 mESCs. For those biological replicates
indicated as (i), (ii) and (iii) in the bar chart, the number of technical replicates, the number of days needed for the experimental animals to reach their
end points, and the sizes of the longest axis of the teratomas are shown per technical replicate. Asterisks (*) indicate that W4 mESCs were
transplanted. n.d., not determined. (C, top): NOD-SCID mice that received transplantation of mESCs cultured in CDSF supplemented with Bmp4 (right)
or the Gsk3b inhibitor (left) are shown. Bars, 1 cm. (C, bottom): Representative histological images are shown. The presence of three germ layers (see
the legend for Fig. 2) is evident in teratomas developed from mESCs cultured in CDSF supplemented with the Gsk3b inhibitor. Bars, 20 mm. (D):
Abundance of each transcript indicated above was examined in mESCs cultured under each condition on the right by 24 cycles of PCR. Ef1a was used
as a reference. White arrowheads indicate the PCR product of c-Myc.
doi:10.1371/journal.pone.0021355.g005
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sporadically developed into teratomas. Further investigation is
required to determine the upstream of Gsk3b in ESCs.
We showed that a CDSF medium supplemented with Bmp4
and LIF supported the proliferation of mESCs that maintained
transcriptional activity of Oct3/4 (supporting information Fig.
S3D). In contrast, Hayashi et al. demonstrated that a CDSF
medium supplemented with Bmp4 supported the differentiation of
trophoblasts from mESCs [47]. However, Hayashi et al. used a
basal CDSF medium that lacked oleic acid and LIF, and plated
mESCs on laminin-coated dishes, but not on collagen IA-coated
dishes. In addition, the presence of LIF under these CDSF
conditions inhibited the differentiation of trophoblasts [47].
Therefore, it is likely that the different chemical composition of
a basal medium contributed to the differentiation of trophoblasts
when Bmp4 was supplemented in the culture.
It is interesting to note that in concert with LIF, Bmp4
suppresses differentiation of the neural lineage in mESCs
maintained under serum-free conditions [14] supplemented with
N2 and B27, which were originally developed to culture a
neuroblastoma cell line [56] and hippocampal neurons [57],
respectively. Mouse ESCs maintained under serum-free condi-
tions supplemented with LIF, Bmp4, N2 and B27 are pluripotent
and can contribute to the germline in chimeric animals [14], and
grew into teratomas (supporting information Table S1 and Fig.
S4). On the other hand, we showed that both the CDSF medium
used in the present study, which contains LIF, and the CDSF
medium supplemented with Bmp4 poorly sustained the tumor-
like growth of mESCs. Taken together, it is suggested with these
data that the cellular pluripotency and the tumor-like growth of
ESCs may be regulated by different mechanisms, and that
extrinsic factors play significant roles in cell fate decisions of
mESCs. It will be interesting to investigate whether ESCs need
unique substrate stiffness to grow into teratomas, because our
previous study showed that stiffer substrates promoted differen-
tiation of mESCs [75].
Gsk3b inhibits the activity of its target c-Myc [24,76], which is
involved in the self-renewal of mESCs [58] and responsible for an
age-associated incidence of tumorigenesis in chimeric mice
generated with mouse iPSCs [77,78]. In contrast, our RT-PCR
results showed that mESCs cultured under CDSF conditions with
the Gsk3b inhibitor failed to significantly upregulate transcription
of Eras and c-Myc (Fig. 5D) but efficiently developed into teratomas
(Fig. 5B, 5C). Thus, we propose that Gsk3b downstream genes
other than c-Myc may regulate the tumor-like growth of ESCs,
which play independent roles from maintaining the self-renewal of
ESCs. In addition, candidate Gsk3b downstream genes responsi-
ble for tumorigenesis in mESCs may act independently from
ERAS in human ESCs [41,42]. Currently, our investigation is
ongoing. Further study to identify the candidate genes and to test
their roles in human ESCs and iPSCs will lead us to establishing a
strategy to significantly improve the safety of human iPSCs.
Materials and Methods
Ethics statement
Use of animals was approved by the Illinois Institutional Animal
Care and Use Committee (protocol # 10093, approved on 6/18/
10).
Cell culture
A mouse embryonic stem cell (mESC) line of R1 [79], which
expresses EGFP under the Oct3/4 promoter [80], was kindly
provided by Dr. William L. Stanford [51]. This Oct3/4::EGFP
mESC line was thawed on feeders and maintained under
standard [81] or chemically-defined serum-free (CDSF) [26]
conditions at 37uC, 5% CO2. The exact number of passages
that this mESC line has gone through is unknown. However,
when these ESCs were brought to our laboratory, they were
passaged on feeders two more times and frozen as a stock.
When these ESCs were thawed on feeders, more frozen stocks
were made at passage 5–7. These stocks were used for the
current study. Under standard conditions, mESCs were
maintained on 0.1% gelatin (Sigma-Aldrich, St. Louis, MO,
http://www.sigmaaldrich.com)-coated tissue culture dishes in
high glucose-Dulbecco’s modified Eagle’s medium (DMEM;
Invitrogen, Carlsbad, CA, http://www.invitrogen.com) supple-
mented with 15% fetal bovine serum (FBS; Invitrogen), 0.1 mM
non-essential amino acids (Invitrogen), 2 mM GlutaMax I
(Invitrogen), 1 mM sodium pyruvate (Invitrogen), 100 U/ml
penicillin and 0.1 mg/ml streptomycin (Sigma-Aldrich),
0.1 mM 2-mercaptoethanol (Sigma-Aldrich), and 1,000 U/ml
LIF (Millipore, Billerica, MA, http://www.millipore.com).
When the mESCs reached 80% to 100% confluence, they
were routinely passaged at a ratio of 1:6 every two days using
TrypLETM Express (Invitrogen). The cells were discarded after
being passaged 10 times onto gelatin-coated dishes. Approxi-
mately 1610
5/cm
2 mESCs maintained under standard condi-
tions were plated onto tissue culture dishes coated with
0.15 mg/ml type IA collagen (Nitta Gelatin Co., Osaka, Japan,
http://www.nitta-gelatin.co.jp), which contain the ESF7 medi-
um (Cell Science & Technology Institute Inc. Miyagi, Japan,
http://www.cstimedia.com) [26] supplemented with 1,000 U/
ml LIF. This was counted as passage 1 under CDSF conditions.
Mouse ESCs at passage 7–12 were used to start CDSF culture.
Mouse ESCs grown under CDSF conditions were split every 3
or 4 days with 0.02% EDTA (Sigma-Aldrich). Similarly, mESCs
of W4 (129S6, purchased at passage 9; Taconic, Hudson, NY,
http://www.taconic.com) and D3 (129S2/SvPas, CRL-1934,
ATCC, Manassas, VA) were used to test CDSF conditions.
When CDSF culture was supplemented with FBS, 0.02%
EDTA was used for passaging cells. Following serum lots were
used to supplement CDSF culture: Lot. 1359246 and 726570,
Invitrogen; Lot. L0228, Atlanta Biologicals (Lawrenceville, GA,
http://www.atlantabio.com); Lot. A74B00Z, Gemini Bio-Prod-
ucts (West Sacramento, CA, http://www.gembio.com). Images
of cell morphology and fluorescence were taken under the same
conditions using an inverted microscope equipped with an epi-
fluorescence lamp (DMI4000B, Leica Microsystems, Wetzlar,
Germany, http://www.leica-microsystems.com) [82,83]. To
measure the frequency of cell doubling, the mESCs were plated
at 1610
6 per one well of 6-well plates. Two days after plating,
the number of cells was counted for the second and third
passages. Cell doubling was calculated based on the following
formula: Cell doubling = log2[(the number of cells 2 days after
plating)/(1610
6)]. Statistical tests were performed using the
Mann-Whitney’s U-test.
To compare the incidence of teratoma formation, another basal
culture medium was prepared by mixing the NeurobasalTM
medium supplemented with B27 (Invitrogen) 1:1 with DMEM/
F12 (Invitrogen) supplemented with N2 (Invitrogen) and 50 mg/ml
bovine serum albumin as described already [84]. The resulting
basal medium was supplemented with either 10 ng/ml LIF and
10 ng/ml Bmp4 (R & D systems) [14], or 1 mM Stemolecule TM
PD0325901 and 3 mM Stemolecule TM CHIR99021 (2i;
Stemgent, Cambridge, MA, https://www.stemgent.com/) [22],
and used to culture mESCs for three passages, which needed seven
days before subcutaneous injection into NOD-SCID mice.
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At the fourth passage under standard or CDSF conditions, the
mESCs were trypsinized and counted. TrypLETM Express was
inactivated with an equal volume of 1 mg/ml soybean trypsin
inhibitor (Sigma-Aldrich). For this purpose, no culture medium
with animal serum was used. One to two million cells were
centrifuged at 1,000 g for 5 min and resuspended into 25 ml PBS,
which was mixed with 25 ml of 0.3 mg/ml type IA collagen.
Mouse ESCs were kept on ice before being injected into NOD-
SCID mice (the Jackson Laboratory, Bar Harbor, ME, http://
www.jax.org) subcutaneously. Animal health was monitored
routinely until the diameter of the tumors reached several few
centimeters at which time the animals reached their end points
and were euthanized. This procedure was approved by the Illinois
Institutional Animal Care and Use Committee. The incidence of
teratoma formation was statistically validated using the Fisher’s
exact probability test.
Histology
Before dissecting the teratomas, pictures of the experimental
animals were taken. The sizes of the longest axis of the teratomas
were measured. Then, the teratomas were surgically dissected out,
cut into smaller pieces, and fixed in 4% paraformaldehyde (Sigma-
Aldrich) at 4uC overnight, followed by dehydration and embedding
in Paraplast plus (Sigma-Aldrich). Sections of 8 mm thickness were
cut and processed for standard hematoxylin and eosin staining.
Immunofluorescence microscopy
The Oct3/4::EGFP ESC line was immunostained essentially as
described previously [75,82]. Goat anti-mouse Nanog (AF2729, R
& D systems) and anti-human Sox2 (sc-17320, Santa Cruz
Biotechnology, Santa Cruz, CA) polyclonal antibodies and a
mouse anti-SSEA1 monoclonal antibody (Developmental Studies
Hybridoma Bank, University of Iowa) were used as primary
antibodies. Alexa Fluor 488 goat anti-mouse IgG (H+L) and Alexa
Fluor 546 donkey anti-goat IgG (H+L) polyclonal antibodies
(Invitrogen) were used as secondary antibodies. Fluorescence
images were taken using the same exposure time (750 msec for
505 nm and 850 msec for 595 nm) and enhanced in the same
way.
Aggregation chimeras
Mouse ESCs cultured under CDSF conditions for 10–12 days
were aggregated with zona-free morulae, which were obtained
from superovulated C57BL/6 females (the Jackson Laboratory)
mated with C57BL/6 males. Aggregated embryos were cultured in
the KSOM medium with 1/2 amino acids (Millipore) for 14–
15 hrs as described previously [79]. Chimeric blastocysts were
transferred to pseudopregnant females at the transgenic mouse
facility on campus.
RT-PCR
A total of 1.6 mg of total RNA extracted from mESCs cultured
under each condition was used to synthesize the first cDNA strand
as previously described [83,85]. PCR mixtures were prepared
using Phusion DNA polymerase (New England Biolab, Ipswich,
MA, http://www.neb.com) according to the manufacturer’s
instructions. The PCR conditions were as follows: initial
denaturing at 98uC for 1 min followed by 19, 21, 23, 24 or 25
cycles of denaturing at 98uC for 10 sec, annealing at 65uC for
30 sec, extension at 72uC for 30 sec, and a final extension at 72uC
for 7.5 min. The primer pairs have previously been described: Eras
[38], Oct4 [86], Esg1 and Ef1a [87], Sox2 [88], and c-Myc [89].
Screening of factors
A day after mESCs were plated under CDSF conditions, these
cultures were supplemented with 10 nM retinol (Sigma-Aldrich) in
100% EtOH with or without 1 nM retinol binding protein (RBP)
from human urine (Sigma-Aldrich), 10 nM all-trans retinoic acid
(Sigma-Aldrich), 10 ng/ml Bmp4 (R & D Systems, Minneapolis,
MN, http://www.rndsystems.com), or 3 mM Stemolecule TM
CHIR99021 in DMSO (Stemgent). Before applying RBP to
culture, buffer exchange was carried out with Amicon Ultra
(Millipore) to remove a preservative. Mouse ESCs grown under
these conditions were split with 0.02% EDTA for 3 passages when
they reached confluence. At the fourth passage, these mESCs were
injected into NOD-SCID mice as described above.
Supporting Information
Figure S1 Anatomical images of NOD-SCID mice trans-
planted with mouse embryonic stem cells. (A-D, F and G):
Teratomas developed from mouse embryonic stem cells (mESCs)
and embryonic carcinomas (F9 in D) cultured under the
conditions indicated are shown. Also, the number of weeks
(wks) needed for the experimental animals to reach their end
points are shown. Bars, 1cm. CDSF+FBS, CDSF culture sup-
plemented with fetal bovine serum; CDSF-Standard, CDSF
conditions followed by standard conditions; CDSF (F9), embry-
onic carcinoma cells F9 maintained under CDSF conditions;
CDSF+Bmp4, CDSF culture supplemented with Bmp4;
CDSF+iGsk3b, CDSF culture supplemented with the Gsk3b
inhibitor. (E): This animal was sacrificed one week after mESCs
cultured under CDSF conditions followed by standard conditions
were transplanted. The rectangle indicates the area shown in the
inset. Bar, 1cm. The inset shows an enlarged image of a tiny mass
of the mESCs depicted by dashed lines with a scale bar of 0.1 cm.
See supporting information Fig. S2 for detail.
(TIF)
Figure S2 Mouse embryonic stem cells exhibited initial
differentiation as early as one week after transplanta-
tion when cultured under CDSF-Standard conditions.
Mouse ESCs were cultured in CDSF for three passages followed
by transfer to standard conditions for two passages prior to
transplantation. (A): An epithelialized cellular mass has aggregates
formed among the collagen fibers (stained pale pink) used to
transplant the mESCs. Rectangles indicate the areas shown in B,
C and D. Bar, 500 mm. (B-D): Two types of cells are prominent,
one of which is reminiscent of keratin pearls (B and D), and the
other that resembles cartilage (C and D). Bars, 20 mm.
(TIF)
Figure S3 Identification of factors that support the
tumor-like growth of mouse embryonic stem cells
maintained under CDSF conditions. (A-E): Phase contrast
(top) and fluorescence (bottom) images of mESCs under CDSF
conditions supplemented with each factor indicated above are
shown. Bars, 20 mm. CDSF+RA, CDSF with retinoic acid;
CDSF+RL, CDSF with retinol; CDSF+RL+RBP, CDSF with
retinol and retinol binding protein; CDSF+Bmp4, CDSF with
Bmp4; CDSF+iGsk3b, CDSF with the Gsk3b inhibitor.
(TIF)
Figure S4 The incidence of teratoma formation was
compared among different CDSF conditions. The sizes of
the teratomas formed (orange bar, left axis) and the number of
days required for the experimental NOD-SCID mice to reach
their end points (blue stars, right axis) were compared among
mESCs cultured under the conditions indicated. Parentheses
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at different passages) per culture condition. Standard errors of the
means are indicated by bars. Two transplantations for ESF7
showed no sign of teratoma formation when paired with the
standard conditions. Standard, Standard conditions; CDSF,
CDSF conditions; BL, other established CDSF conditions
supplemented with N2, B27, Bmp4 and LIF; 2i, other established
CDSF conditions supplemented with N2, B27, and pharmaco-
logical inhibitors of Erk and Gsk3b.
(TIF)
Figure S5 Expression levels of markers were compared
among different culture conditions. Abundance of each
transcript indicated above was examined in mESCs cultured
under each condition on the right by 19, 21 and 23 cycles of PCR
(indicated by triangles). Ef1a was used as a reference. White
arrowheads indicate the PCR product of c-Myc.
(TIF)
Table S1 Effects of serum on the tumorigenicity of
mouse embryonic stem cells.
(DOCX)
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